Trisomy X is a chromosomal condition in which a female has an additional X chromosome, usually producing a total of 47 chromosomes rather than 46. The typical chromosome pattern is written 47,XXX. Its effects vary widely: many affected individuals have no obvious physical differences and remain undiagnosed, while others experience speech and language delays, learning difficulties, or other developmental and medical features. The condition occurs in approximately 1 in 1,000 female births.
Genetic basis
Most females have two X chromosomes. In trisomy X, an additional X chromosome is present in all or some cells. The condition usually results from nondisjunction, an error in chromosome separation during the formation of an egg or sperm. An error during early embryonic cell division can also produce the condition. Most cases arise sporadically rather than being inherited through a family. The likelihood increases with maternal age, although affected births occur across maternal ages.
In a typical female cell, most genes on all but one X chromosome are largely silenced through X inactivation. In 47,XXX cells, two X chromosomes are largely inactivated. However, some genes escape this process. The resulting increase in gene expression helps explain why an additional X chromosome can affect growth and development despite extensive inactivation.
Some individuals have mosaicism, meaning that different cells have different chromosome patterns. A common example is 46,XX/47,XXX mosaicism. The effects depend partly on which tissues contain each cell population; the proportion measured in a blood sample does not necessarily represent every tissue or predict an individual's abilities or health.
Trisomy X is distinct from Turner syndrome, which involves complete or partial loss of an X chromosome, and Klinefelter syndrome, most commonly associated with a 47,XXY chromosome pattern.
Clinical features
Growth and physical development
Many affected individuals have no distinctive appearance. Taller-than-average stature is common, sometimes with relatively long legs. Other possible features include reduced muscle tone, curved little fingers, and minor differences in facial appearance. None of these features is sufficient to establish the condition.
Motor milestones, such as sitting or walking, may occur later than average. Coordination difficulties can persist into childhood or adulthood, but their severity varies considerably.
Language, learning, and behavior
Speech and language development is a commonly affected area. Difficulties may involve expressive language, understanding complex spoken information, or reading and writing. Some individuals also have problems with working memory, attention, planning, or processing speed.
Intellectual ability spans a broad range, and many affected individuals have intelligence within the typical range. Intellectual disability is not an inevitable feature. A chromosome result alone cannot reliably predict educational attainment or independent functioning.
Studies report increased rates of attention-deficit/hyperactivity disorder, anxiety disorders, and social or emotional difficulties. These associations do not mean that every individual will develop a psychiatric or neurodevelopmental condition.
Other medical features
Seizures and structural differences involving the kidneys or urinary tract occur in a minority of affected individuals. The presence and severity of associated medical conditions vary, and many people do not have major congenital abnormalities.
Puberty and sexual development are usually typical. Many affected women have regular menstrual cycles and can become pregnant. However, primary ovarian insufficiency—reduced ovarian function before age 40—has been reported more often than in the general population. Its frequency in trisomy X is not precisely established, and infertility is not a universal consequence.
Diagnosis
Diagnosis is established by chromosome testing, most commonly a karyotype showing an additional X chromosome. Chromosomal microarray testing can also identify an extra X chromosome, although the detection of low-level mosaicism depends on the method and sample.
After birth, testing may follow investigation of developmental delays, learning difficulties, unusually tall stature, or reproductive concerns. Some diagnoses are incidental.
During pregnancy, cell-free DNA screening can indicate an increased likelihood of trisomy X. This is a screening result, not a definitive fetal diagnosis: the DNA examined is predominantly placental in origin, and results can be influenced by placental mosaicism or maternal chromosome differences. Diagnostic testing using chorionic villus sampling or amniocentesis examines chromosomes more directly, although mosaic results may require additional interpretation.
Neither prenatal nor postnatal chromosome testing can precisely predict the eventual developmental or medical presentation.
Support and clinical care
There is no treatment that removes the additional chromosome. Care addresses the particular developmental, educational, psychological, or medical needs that are present.
Services used in clinical practice include speech-language therapy, educational support, and occupational therapy or physical therapy for motor and coordination difficulties. Associated conditions, including seizures, attention difficulties, or anxiety, are assessed and treated according to their individual presentation.
Genetic counseling explains the chromosome finding, its variable effects, and the limits of prediction. In families with an affected child, recurrence is generally uncommon, although interpretation depends on the specific chromosome findings and parental circumstances.
Epidemiology and limits of evidence
Trisomy X was first described in 1959. Despite its estimated birth frequency, many cases are never recognized because there may be few noticeable symptoms or no reason to perform chromosome testing.
This underdiagnosis complicates research. Studies recruiting participants from developmental or specialist clinics can overrepresent individuals with greater difficulties. Groups identified through prenatal testing or population screening may show a broader and often milder range of outcomes. Differences in recruitment, sample size, age, and access to support limit the extent to which findings from any single study describe all people with trisomy X.